UC TUR.OP.END. BULL EAM/ DE000HC1BPL9 /
| 8/15/2024 3:46:04 PM | Chg.+0.0400 | Bid8/15/2024 | Ask8/15/2024 | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 1.1000EUR | +3.77% | - Bid Size: 125,000 |
- Ask Size: 125,000 |
A2A | 0.9473 EUR | 12/31/2078 | Call |
GlobeNewswire
5/6
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
3/19
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financ...
GlobeNewswire
3/6
iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
GlobeNewswire
11/28/2023
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update
GlobeNewswire
11/7/2023
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
GlobeNewswire
11/7/2023
iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates
GlobeNewswire
11/6/2023
Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy...
Newsfile Corp
10/4/2023
Noda and Tickets Travel Network Forge Partnership for Seamless Travel Payments
GlobeNewswire
9/21/2023
Bluejay Therapeutics expands management team and hired Christopher Holterhoff as senior Vice Preside...
GlobeNewswire
9/20/2023
Innovative Payment Solutions Announces Funding of Second $500,000 Capital Contribution to IPSIPay Ex...
GlobeNewswire
9/5/2023
Portage Biotech Announces Collaboration with Merck to Evaluate Two Next-Generation Adenosine Antagon...
GlobeNewswire
8/30/2023
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023 and Business Update
GlobeNewswire
3/10/2022
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financ...
GlobeNewswire
3/3/2022
Corvus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2021 Finan...
GlobeNewswire
2/10/2022
Sosei Heptares Operational Highlights and Consolidated Results for 12 Months ended 31 December 2021
GlobeNewswire
2/2/2022
Bluejay Therapeutics Announces the Appointment of Nancy Shulman, M.D., as Chief Medical Officer
GlobeNewswire
1/14/2022
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Initiated Phase 1/1b Clinical Trial o...
GlobeNewswire
12/9/2021
iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology...
GlobeNewswire
11/12/2021
Corvus Pharmaceuticals Presents Updated Data from Mupadolimab (Anti-CD73) Phase 1/1b Clinical Trial ...
GlobeNewswire
11/10/2021
Corvus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
